Defendant Name: Acadia Healthcare Company, Inc.

Defendant Type: Public Company
SIC Code: 9999
CUSIP: 00404A10

Initial Case Details

Legal Case Name In the Matter of Acadia Healthcare Company, Inc.
First Document Date 09-Sep-2024
Initial Filing Format Administrative Action
File Number 3-22079
Allegation Type Other

Violations Alleged

Other
• Rule 21F-17(a) Exchange Act

Resolutions

First Resolution Date 09-Sep-2024
Headline Total Penalty and Disgorgement $1,386,000

Related Documents:

34-100970 09-Sep-2024 Administrative Proceeding
Order Instituting Cease-and-Desist Proceedings Pursuant to Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
On September 9, 2024, the SEC instituted settled cease-and-desist proceedings against Acadia Healthcare Company, Inc., stating: "As a regular part of its business, Acadia enters into employment agreements with new employees and separation agreements with departing employees. These agreements define the rights and responsibilities of the company and the employee during the employment relationship and after the employee’s departure. . . [T]hese provisions created impediments to participation in the Commission’s whistleblower program by requiring employees to forego either their right to file a complaint with the Commission staff or the financial award they might receive for doing so."
2024-118_3-22079 09-Sep-2024 Press Release--Administrative Proceeding
SEC Charges Seven Public Companies with Violations of Whistleblower Protection Rule
On September 9, 2024, the SEC stated: "today announced settled charges against seven public companies for using employment, separation, and other agreements that violated rules prohibiting actions to impede whistleblowers from reporting potential misconduct to the SEC."